WO2005009472A3 - Dispersible pharmaceutical composition for treatment of mastitis and otic disorders - Google Patents

Dispersible pharmaceutical composition for treatment of mastitis and otic disorders Download PDF

Info

Publication number
WO2005009472A3
WO2005009472A3 PCT/IB2004/002474 IB2004002474W WO2005009472A3 WO 2005009472 A3 WO2005009472 A3 WO 2005009472A3 IB 2004002474 W IB2004002474 W IB 2004002474W WO 2005009472 A3 WO2005009472 A3 WO 2005009472A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
pharmaceutical composition
mastitis
dispersible pharmaceutical
otic disorders
Prior art date
Application number
PCT/IB2004/002474
Other languages
French (fr)
Other versions
WO2005009472A2 (en
Inventor
Nancy Jean Britten
Niki Ann Waldron
Jeffrey Lynn Watts
John Walter Hallberg
John William Ii Burns
Original Assignee
Pharmacia & Upjohn Co Llc
Nancy Jean Britten
Niki Ann Waldron
Jeffrey Lynn Watts
John Walter Hallberg
John William Ii Burns
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc, Nancy Jean Britten, Niki Ann Waldron, Jeffrey Lynn Watts, John Walter Hallberg, John William Ii Burns filed Critical Pharmacia & Upjohn Co Llc
Priority to EP04744125A priority Critical patent/EP1656159A2/en
Priority to BRPI0412923-7A priority patent/BRPI0412923A/en
Priority to MXPA06001192A priority patent/MXPA06001192A/en
Priority to CA002529405A priority patent/CA2529405A1/en
Priority to AU2004258746A priority patent/AU2004258746A1/en
Priority to JP2006521704A priority patent/JP2007500692A/en
Publication of WO2005009472A2 publication Critical patent/WO2005009472A2/en
Publication of WO2005009472A3 publication Critical patent/WO2005009472A3/en
Priority to IL171893A priority patent/IL171893A0/en
Priority to NO20055466A priority patent/NO20055466L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A method is provided for treatment and/or prevention of an infective condition in a fluid-containing organ having a natural exterior orifice, such as the udder of a milk-producing animal or an ear of a subject. The invention also relates to a dispersible pharmaceutical composition suitable for infusion into the organ according to the method of the invention, and to a process for preparing such a composition.
PCT/IB2004/002474 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders WO2005009472A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP04744125A EP1656159A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
BRPI0412923-7A BRPI0412923A (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for the treatment of mastitis and optical disorders
MXPA06001192A MXPA06001192A (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders.
CA002529405A CA2529405A1 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
AU2004258746A AU2004258746A1 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
JP2006521704A JP2007500692A (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treating mastitis and ear disorders
IL171893A IL171893A0 (en) 2003-07-31 2005-11-10 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
NO20055466A NO20055466L (en) 2003-07-31 2005-11-18 Dispersible pharmaceutical composition for treating mastitis and otic disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
US60/492,178 2003-07-31

Publications (2)

Publication Number Publication Date
WO2005009472A2 WO2005009472A2 (en) 2005-02-03
WO2005009472A3 true WO2005009472A3 (en) 2005-04-07

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/002474 WO2005009472A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Country Status (13)

Country Link
EP (1) EP1656159A2 (en)
JP (1) JP2007500692A (en)
KR (1) KR100807414B1 (en)
CN (1) CN1812814A (en)
AU (1) AU2004258746A1 (en)
BR (1) BRPI0412923A (en)
CA (1) CA2529405A1 (en)
IL (1) IL171893A0 (en)
MX (1) MXPA06001192A (en)
NO (1) NO20055466L (en)
RU (1) RU2329064C2 (en)
WO (1) WO2005009472A2 (en)
ZA (1) ZA200600850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509992A (en) * 2004-04-22 2007-10-16 Pfizer Prod Inc cluttered cefovecin sodium salt stabilization method
CA2877794C (en) * 2012-06-29 2020-08-04 Bayer Animalhealth Gmbh Pharmaceutical compositions and treatment of mastitis
BR112016000381A8 (en) * 2013-08-12 2020-01-07 Novartis Ag use of one or more antibiotic compounds to treat optical infections and device for use as a kit
CN104622875B (en) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 Breast injection medicament for resisting cow mastitis and preparation method thereof
PT3370698T (en) * 2015-11-03 2022-03-02 Zoetis Services Llc Sol-gel polymer composites and uses thereof
RU2663070C1 (en) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Method for otomycosis treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
WO1998025621A1 (en) * 1996-12-09 1998-06-18 Pharmacia & Upjohn Company Improved pharmaceutical compositions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OWENS W E ET AL: "DETERMINATION OF MILK AND MAMMARY TISSUE CONCENTRATIONS OF CEFTIOFUR AFTER INTRAMAMMARY AND INTRAMUSCULAR THERAPY", JOURNAL OF DAIRY SCIENCE, AMERICAN DAIRY SCIENCE ASSOCIATION. CHAMPAIGN, ILLINOIS, US, vol. 73, no. 12, 1990, pages 3449 - 3456, XP002291861, ISSN: 0022-0302 *

Also Published As

Publication number Publication date
WO2005009472A2 (en) 2005-02-03
MXPA06001192A (en) 2006-04-11
KR100807414B1 (en) 2008-02-25
IL171893A0 (en) 2006-04-10
JP2007500692A (en) 2007-01-18
RU2329064C2 (en) 2008-07-20
RU2006102665A (en) 2006-06-10
NO20055466D0 (en) 2005-11-18
AU2004258746A1 (en) 2005-02-03
CN1812814A (en) 2006-08-02
CA2529405A1 (en) 2005-02-03
KR20060033031A (en) 2006-04-18
EP1656159A2 (en) 2006-05-17
NO20055466L (en) 2006-04-21
BRPI0412923A (en) 2006-09-26
ZA200600850B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
WO2005009436A8 (en) Dispersible formulation of an anti-inflammatory agent
TWI265809B (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2004060345A3 (en) Dispersible pharmaceutical compositions
WO2006032500A3 (en) Immunogenic composition
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
CN104059013B8 (en) 1-aryl-3-azabicyclo [3.1.0] hexane: its preparation method and for treating the purposes of neuropsychiatric disorders
MXPA05009978A (en) Dispersible formulation of an anti-inflammatory agent.
EG22882A (en) Benzoylpyridine derivative or its satl fungicide containing it as an active ingredient its production process and intermediate for producing it
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
EP1269854A8 (en) Clear dairy drink and method for producing same
WO2008074793A3 (en) A method for producing cheese
WO2003049752A3 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
WO2005063764A3 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
WO2009080609A3 (en) Method of increasing the milk and/or meet quantity of silage-fed animals
WO2005009472A3 (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
EP1308094A3 (en) Chocolate crumb flavour manipulation
AU2003202153A1 (en) Composition for preventing or treating mastitis of dairy cattle
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
WO2005094790A8 (en) Liposomal formulations
ATE300874T1 (en) FOOD GRADE TRANSGLUTAMINASE INHIBITORS AND THEIR USE
WO2008035370A3 (en) Compositions for prevention and treatment of mastitis and metritis
WO2005063757A3 (en) Novel crystalline forms of temozolomide
WO2003030820A3 (en) Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae
WO2003007878A3 (en) Antifungal agents of sordarin derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 171893

Country of ref document: IL

Ref document number: 2004258746

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 5196/DELNP/2005

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2004258746

Country of ref document: AU

Date of ref document: 20040719

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004258746

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 543914

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2529405

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 20048183007

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2006/00850

Country of ref document: ZA

Ref document number: 2006521704

Country of ref document: JP

Ref document number: 200600850

Country of ref document: ZA

Ref document number: 12006500243

Country of ref document: PH

Ref document number: PA/a/2006/001192

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020067002174

Country of ref document: KR

Ref document number: 2006102665

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 2004744125

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067002174

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2004744125

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0412923

Country of ref document: BR